Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

NCT03642028 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

190

Enrollment

FED

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders
Stress Disorders, Posttraumatic

Interventions

DRUG: Suvorexant
OTHER: Placebo

Sponsor

VA Office of Research and Development